WHO WE ARE
Company Overview
Our Journey
Manufacturing
Environment Health & Safety
Pan India Reach
In the News
Life
@
Eris
BRANDS OF ERIS
Leading Brands of Eris
Anti-Diabetes
Cardiovascular
Nutrition
Neuroscience
Gynaecology
All Brands
PATIENT CARE
PCI Overview
Cardiovascular Care
Diabetic Care
Pain Management
Gynaecological Care
PIONEERING STUDIES
India Heart Study
India Diabetes Study
HEALTH & LIVING
Diabetes
Cardiology
Hypertension
Nutrition
Gynaecology
Orthopedic
Gastroenterology
Pediatric
INVESTORS
Eris at a Glance
Announcements & Notices
Financials
Corporate Governance
Shareholders Information
Analysts Coverage
GROUP COs
Eris MJ Biopharm Private Limited
Eris Oaknet Healthcare Pvt Ltd
Contact Us
Who We Are
Company Overview
Our Journey
Manufacturing
Environment Health & Safety
PAN India Reach
In The News
Life @ Eris
Brands of Eris
Leading brands of Eris
Anti-Diabetes
CARDIOVASCULAR
Nutrition
Neuroscience
Gynaecology
All Brands
Patient Care
PCI Overview
Cardiovascular care
Diabetic Care
Pain Management
Gynaecological Care
PIONEERING STUDIES
India Heart Study
India Diabetes Study
Health & Living
Diabetes
Cardiology
Hypertension
Nutrition
Gynaecology
Orthopedic
Gastroenterology
Pediatric
Investors
Eris at a Glance
Announcements & Notices
Financials
Corporate Governance
Shareholder’s Information
Analysts Coverage
Group Cos
Eris MJ Biopharm Private Limited
Eris Oaknet Healthcare Pvt Ltd
Contact Us
WHO WE ARE
Menu Item
BRANDS OF ERIS
Pages Column 1
Leading Brands of Eris
Anti-Diabetes
Cardiovascular
Nutrition
Neuroscience
Gynaecology
All Brands
PATIENT CARE
Column
PCI Overview
Cardiovascular Care
Diabetic Care
Pain Management
Gynaecological Care
PIONEERING STUDIES
Column
India Heart Study
India Diabetes Study
HEALTH & LIVING
Column
Diabetes
Cardiology
Hypertension
Nutrition
Gynaecology
Orthopedic
Gastroenterology
Pediatric
INVESTORS
Column
Eris at a Glance
Announcements & Notices
Financials
Corporate Governance
Shareholders Information
Analysts Coverage
GROUP COs
Column
Eris MJ Biopharm Private Limited
EHPL Overview
Generics
Medical Devices & Diagnostics
Eris Oaknet Healthcare Pvt Ltd
Contact Us
Who We Are
Company Overview
Our Journey
Manufacturing
Environment Health & Safety
PAN India Reach
In The News
Life @ Eris
Brands of Eris
Leading brands of Eris
Anti-Diabetes
CARDIOVASCULAR
Nutrition
Neuroscience
Gynaecology
All Brands
Patient Care
PCI Overview
Cardiovascular care
Diabetic Care
Pain Management
Gynaecological Care
PIONEERING STUDIES
India Heart Study
India Diabetes Study
Health & Living
Diabetes
Cardiology
Hypertension
Nutrition
Gynaecology
Orthopedic
Gastroenterology
Pediatric
Investors
Eris at a Glance
Announcements & Notices
Financials
Corporate Governance
Shareholder’s Information
Analysts Coverage
Group Cos
Eris MJ Biopharm Private Limited
Eris Oaknet Healthcare Pvt Ltd
Contact Us
Search:
Eris Home
>
Investors
>
Financials
Financial Results
Select Year
FY 2022-2023
FY 2021-2022
FY 2020-2021
FY2019-2020
FY 2018-2019
FY 2017-2018
Select Quarter
Q1 - (APRIL TO JUNE)
Q2 - (JULY TO SEPTEMBER)
Q3 - (OCTOBER TO DECEMBER)
Q4 - (JANUARY TO MARCH)
Select Quarter
Q1 - (APRIL TO JUNE)
Q2 - (JULY TO SEPTEMBER)
Q3 - (OCTOBER TO DECEMBER)
Q4 - (JANUARY TO MARCH)
FINANCIAL RESULTS
Q1 – (APRIL TO JUNE)
Financial Results for 30th June 2022
Eris Investor Presentation 30th June 2022
Transcript of the Analyst and Investor Conference call Q1FY23
Q1 FY23- Earnings call Recording
Newspaper advertisement for Extract of Result for June, 2022
Notice of the Board meeting on August 05, 2022
Intimation for Earnings Call Q1FY23
Press release: Q1 – (APRIL TO JUNE)
Q2 – (JULY TO SEPTEMBER)
Financial Results for 30th September 2022
Eris Investor Presentation 30th September 2022
Transcript-of-the-Analyst-and-Investor-Conference-Call-Q2FY23
Q2 FY23- Earnings call Recording
Newspaper advertisement for Extract of Result for September, 2022
Notice of the Board meeting on October 20, 2022
Intimation for Earnings Call Q2FY23
Q3 – (OCTOBER TO DECEMBER)
Financial Results for 31st December 2022
Eris Investor Presentation 31st December 2022
Transcript of the Analyst and Investor Conference call Q3FY23
Newspaper publication of Financial Results – Financial Express 19-01-2023
Q3 FY23 Earning Call Recording
Intimation for Earnings Call Q3FY23
Notice of the Board meeting on January 17, 2023
Q4 – (JANUARY TO MARCH)
Financial Results for 31st March, 2023
Eris Investor Presentation 31 March 2023
Newspaper publication of Financial Results – Financial Express 18-05-2023
Transcript of the Analyst and Investor Conference call Q4FY23
Q4 FY23 Earning Call Recording
Notice of the Board meeting on May 17, 2023
Intimation for Earnings Call Q4FY23
Q1 – (APRIL TO JUNE)
Financial Results for 30th June 2021
Eris Investor Presentation 30th June 2021
Transcript of the Analyst and Investor Conference call Q1FY22
Q1 FY22- Earnings call Recording
Newspaper advertisement for Extract of Result for June, 2021
Notice of the Board meeting on July 29, 2021
Intimation for Earnings Call Q1FY22
Press release: Q1 – (APRIL TO JUNE)
Q2 – (JULY TO SEPTEMBER)
Financial Results for 30th September 2021
Eris Investor Presentation 30th September 2021
Transcript of the Analyst and Investor Conference call Q2FY22
Q2 FY22- Earnings call Recording
Newspaper advertisement for Extract of Result for September, 2021
Notice of the Board meeting on October 29, 2021
Intimation for Earnings Call Q2FY22
Press release: Q2 – (JULY TO SEPTEMBER)
Q3 – (OCTOBER TO DECEMBER)
Financial Results for 31st December, 2021
Eris Investor Presentation 31st December, 2021
Eris Lifesciences Limited Q3FY22 Revenues at INR 3,322 mn, up 7.0% YoY
Transcript of the Analyst and Investor Conference call Q3FY22
Q3 FY22 – Earnings Call Recording
Newspaper advertisement for Extract of Result for December, 2021
Notice of the Board meeting on January 28, 2022
Intimation for Earnings Call Q3FY22
Press release: Q3 – (OCTOBER TO DECEMBER)
Q4 – (JANUARY TO MARCH)
Financial Results for 31st March, 2022
Eris Investor Presentation 31 March 2022
Transcript of the Analyst and Investor Conference Call Q4FY22
Q4 FY22 Earnings Call Recording
Newspaper advertisement for Extract of Result for March, 2022
Notice of the Board Meeting on 3rd May, 2022
Intimation for Earnings Call Q4FY22
Q1 – (APRIL TO JUNE)
Financial Results for 30th June 2020
Eris Investor Presentation 30th June 2020
Transcript of the Analyst and Investor Conference call Q1FY21
Newspaper advertisement for Extract of Result for June, 2020
Notice of the Board meeting on August 04, 2021
Intimation for Earnings Call Q1FY21
Press release: Q1 – (APRIL TO JUNE)
Q2 – (JULY TO SEPTEMBER)
Financial Results for 30th September 2020
Eris Investor Presentation 30th September 2020
Transcript of the Analyst and Investor Conference call Q2FY21
Newspaper advertisement for Extract of Result for September, 2020
Notice of the Board meeting on November 03, 2020
Intimation for Earnings Call Q2FY21
Disclosure of Related Party Transactions on a Consolidated Basis – September 2020
Press release: Q2 – (JULY TO SEPTEMBER)
Q3 – (OCTOBER TO DECEMBER)
Financial Results for 31st December 2020
Eris Investor Presentation 31st December 2020
Transcript of the Analyst and Investor Conference call Q3FY22
Newspaper advertisement for Extract of Result for December, 2020
Notice of the Board meeting on January 28, 2021
Intimation for Earnings Call Q3FY21
Press release: Q3 – (OCTOBER TO DECEMBER)
Q4 – (JANUARY TO MARCH)
Financial Results for 31st March 2021
Eris Investor Presentation 31th March2021
Transcript of the Analyst and Investor Conference call Q4FY21
Q4 FY21- Earnings call Recording
Newspaper advertisement for Extract of Result for March, 2021
Notice of the Board meeting on May 13, 2021
Intimation for Earnings Call Q4FY21
Press release: Q4 – (JANUARY TO MARCH)
Q1 – (APRIL TO JUNE)
Financial Results for 30th June 2019
Eris Investor Presentation 30th June 2019
Transcript of the Analyst and Investor Conference call Q1FY20
Newspaper advertisement for Extract of Result for June, 2019
Notice of the Board meeting on July 27, 2019
Intimation for Earnings Call Q1FY20
Press release: Q1 – (APRIL TO JUNE)
Q2 – (JULY TO SEPTEMBER)
Financial Results for 30th September 2019
Eris Investor Presentation 30th September 2019
Transcript of the Analyst and Investor Conference call Q2FY20
Newspaper advertisement for Extract of Result for September, 2019
Notice of the Board meeting on November 07, 2019
Intimation for Earnings Call Q2FY20
Disclosure of Related Party Transactions on a Consolidated Basis – September 2019
Press release: Q2 – (JULY TO SEPTEMBER)
Q3 – (OCTOBER TO DECEMBER)
Financial Results for 31st December 2019
Eris Investor Presentation 31st December 2019
Transcript of the Analyst and Investor Conference call Q3FY20
Newspaper advertisement for Extract of Result for December, 2019
Notice of the Board meeting on February 14, 2020
Intimation for Earnings Call Q3FY20
Press release: Q3 – (OCTOBER TO DECEMBER)
Q4 – (JANUARY TO MARCH)
Financial Results for 31st March 2020
Eris Investor Presentation 31th March2020
Transcript of the Analyst and Investor Conference call Q4FY20
Q4 FY20- Earnings call Recording
Notice of the Board meeting on June 26, 2020
Intimation for Earnings Call Q4FY20
Disclosure of Related Party Transactions on a Consolidated Basis – March, 2020
Press release: Q4 – (JANUARY TO MARCH)
Q1 – (APRIL TO JUNE)
Financial Result for 30th June, 2018
Eris Investor Presentation 30th June,2018
Transcript of the Analyst and Investor Conference call Q1FY19
Newspaper advertisement for Extract of Result for June, 2018
Intimation for Earnings Call Q1FY2018-2019
Press release: Q1 – (APRIL TO JUNE)
Q2 – (JULY TO SEPTEMBER)
Financial Results for 30th September 2018
Eris Investor Presentation 30th September 2018
Transcript of the Analyst and Investor Conference call Q2FY19
Newspaper advertisement for Extract of Result for September, 2018
Intimation for Earnings Call Q2FY19
Press release: Q2 – (JULY TO SEPTEMBER)
Q3 – (OCTOBER TO DECEMBER)
Financial Results for 31st December 2018
Eris Investor Presentation 31st December 2018
Transcript of the Analyst and Investor Conference call Q3FY19
Newspaper advertisement for Extract of Result for December, 2018
Intimation for Earnings Call Q3FY19
Press release: Q3 – (OCTOBER TO DECEMBER)
Q4 – (JANUARY TO MARCH)
Financial Results for 31st March 2019
Eris Investor Presentation 31th March 2019
Transcript of the Analyst and Investor Conference call Q4FY19
Newspaper advertisement for Extract of Result for March, 2021
Notice of the Board meeting on May 21, 2019
Disclosure of Related Party Transactions on a Consolidated Basis
Intimation for Earnings Call Q4FY19
Press release: Q4 – (JANUARY TO MARCH)
Q1 – (APRIL TO JUNE)
Financial Result for 30th June, 2017
Transcript of the Analyst and Investor Conference call
Newspaper advertisement for Extract of Result for June, 2017
Intimation of Analyst Institutional Investor Call – August 18, 2017
Press release: Q1 – (APRIL TO JUNE)
Q2 – (JULY TO SEPTEMBER)
Financial Results for 30th September 2017
Eris Investor Presentation 30th September 2017
Transcript of the Analyst and Investor Conference call Q2FY18
Newspaper advertisement for Extract of Result for September, 2017
Intimation of Analysts & Institutional Investor call – November 20, 2017
Press release: Q2 – (JULY TO SEPTEMBER)
Q3 – (OCTOBER TO DECEMBER)
Financial Result for 31st December, 2017
Transcript of the Analyst and Investor Conference call- Q3FY18
Newspaper advertisement for Extract of Result for December, 2017
Intimation of Analyst Institutional Investor Call – February 13, 2018
Press release: Q3 – (OCTOBER TO DECEMBER)
Q4 – (JANUARY TO MARCH)
Financial Result for 31st March, 2018
Eris Investor Presentation for 31st March, 2018
Transcript of the Analyst and Investor Conference Call- Q4FY18
Newspaper advertisement for Extract of Result for March, 2018
Intimation of Analysts & Institutional Investor call – May 28, 2018
Press release: Q4 – (JANUARY TO MARCH)
ANNUAL REPORTS
Annual Report 2021-22
Annual Report 2020-21
Annual Report 2019-20
Annual Report 2018-19
Annual Report 2017-18
Annual Report 2016-17
SUBSIDIARIES
Financial Statement – EPPL
EPPL- 2021-22
EPPL-2020-21
Financial Statement – AHPL
AHPL-2019-20
AHPL-2018-19
AHPL-2017-18
AHPL-2016-17
Financial Statement- EMJ
EMJ-2021-22
KHPL-2020-21
KHPL-2019-20
KHPL-2018-19
KHPL-2017-18
KHPL-2016-17
Financial Statement - ETPL
ETPL-2019-20
ETPL-2018-19
ETPL-2017-18
ETPL-2016-17
Financial Statement – EHPL
EHPL- 2021-22
EHPL- 2020-21
EHPL- 2019-20
EHPL- 2018-19
EHPL- 2017-18
Financial Statement – AHL
AHL-2021-22
AHL-2020-21
UTH-2019-20
UTH-2018-19
UTH-2017-18
Financial Statement- ETL
ETL-2021-22